Ishita Drugs Faces Technical Shift Amidst Positive Financial Results and Long-Term Challenges
Ishita Drugs & Industries has experienced a recent adjustment in its evaluation, influenced by shifts in technical indicators. While the company reported positive financial results for Q1 FY25-26, challenges remain regarding its long-term fundamental strength, as indicated by various performance metrics.
Ishita Drugs & Industries, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting changes in its technical indicators. The stock's technical trend has shifted from a mildly bearish stance to a bearish outlook, as indicated by various metrics.In terms of technical analysis, the Moving Averages are currently bearish, while the MACD shows a mildly bullish signal on a weekly basis but leans towards a mildly bearish position monthly. The Bollinger Bands also reflect a bearish trend, particularly on a monthly basis. The KST and Dow Theory indicators present a bearish sentiment as well, suggesting a cautious approach to the stock's performance.
Despite these technical adjustments, Ishita Drugs has reported positive financial results for the quarter ending Q1 FY25-26, with net sales reaching Rs 14.09 crore and a profit after tax of Rs 0.83 crore. However, the company faces challenges with long-term fundamental strength, as evidenced by an average Return on Equity (ROE) of 8.40% and a weak EBIT to Interest ratio of 0.85.
Overall, the recent revision in its score reflects a complex interplay of technical trends and financial performance indicators for Ishita Drugs & Industries.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
